CALA (OTC)
CALITHERA BIOSCIENCES INC
$0.000200
+0.000000 (+0.00%)
Prev close: $0.000200
Company Information
- Exchange
- OTC Link
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Susan M. Molineaux
- Asset Type
- otc
- Website
- —
Fundamentals
- Market Cap
- $0.02M
- Employees
- 63
- P/E (TTM)
- —
- P/B (TTM)
- -3.49
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
0
Buy
3
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2022 (Q3)
|
$-2.01 | $-1.97 | -0.0448 | -2.28% |
|
Jun 2022 (Q2)
|
$-1.59 | $-2.71 | +1.1156 | +41.23% |
|
Mar 2022 (Q1)
|
$-3.60 | $-3.77 | +0.1740 | +4.61% |
|
Dec 2021 (Q4)
|
$-4.80 | $-4.90 | +0.0960 | +1.96% |
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $42.07M |
| Operating Income/Loss | -$42.07M |
| Income/Loss From Continuing Operations After Tax | -$39.65M |
| Income/Loss From Continuing Operations Before Tax | -$39.65M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$39.65M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$39.65M |
| Net Income/Loss Available To Common Stockholders, Basic | -$21.29M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | -$18.36M |
| Preferred Stock Dividends And Other Adjustments | -$18.36M |
| Basic Earnings Per Share | -$4.60 |
| Diluted Earnings Per Share | -$7.94 |
| Basic Average Shares | 4,633,000 |
| Diluted Average Shares | 4,992,000 |
| Assets | $28.68M |
| Current Assets | $26.62M |
| Noncurrent Assets | $2.05M |
| Fixed Assets | $434.00K |
| Other Non-current Assets | $1.62M |
| Liabilities | $8.28M |
| Current Liabilities | $7.39M |
| Accounts Payable | $732.00K |
| Wages | $1.79M |
| Other Current Liabilities | $4.86M |
| Noncurrent Liabilities | $894.00K |
| Equity | $20.39M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $20.39M |
| Liabilities And Equity | $28.68M |
| Net Cash Flow From Operating Activities | -$43.61M |
| Net Cash Flow From Operating Activities, Continuing | -$43.61M |
| Net Cash Flow From Investing Activities | -$133.00K |
| Net Cash Flow From Investing Activities, Continuing | -$133.00K |
| Net Cash Flow From Financing Activities | $9.66M |
| Net Cash Flow From Financing Activities, Continuing | $9.66M |
| Net Cash Flow | -$34.09M |
| Net Cash Flow, Continuing | -$34.09M |
| Comprehensive Income/Loss | -$39.65M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$39.65M |
| Other Comprehensive Income/Loss | $0.00 |